GlaxoSmithKline, Johnson & Johnson and DaVita HealthCare Partners had invested in the medical device provider before it floated above its range.

The Delta, United, Union Square Hospitality and Liberty Media-backed identity management technology developer's shares increased 29% on their first day of trading.

Less than a year after raising $72.6m in its series A round, Aerovate Therapeutics has gone public following an IPO worth more than $121m.

The Bertelsmann, Red Star Macalline and SoftBank-backed grocery delivery service floated in a $95.7m downsized initial public offering this week.

SoftBank, Uber and Tencent are the largest external shareholders of the on-demand ride service, which has floated in an upsized $4.44bn offering.

The Qualcomm Ventures and Samsung Ventures-backed XDR cybersecurity platform developer is going public in an offering sized above $1.22bn.

BMW i Ventures, Dell Technologies Capital and RBVC are all scoring exits from the manufactured parts marketplace, which has priced its IPO above the range.

Gilead Sciences is co-leading a $75m PIPE deal for the coronavirus drug developer, which is set take the place on Nasdaq held by FS Development Corp II later this year.

The Gruner + Jahr and SIG-backed content discovery technology developer is set to float on the Nasdaq Global Select Market, following a failed merger with Taboola in 2020.

CMU-founded language learning platform developer Duolingo was valued at $2.4bn as of its last funding round in November 2020.